Accessibility Menu
Fuss Brands logo

Fuss Brands(OTC) FBDS

Market Cap$1.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1997)-100%
5 Year-98%
1 Year+60%
1 Month-21%
$0.08
+0.00%
+0.00Today
Fuss Brands last closing stock price
MetricPriceDate
Last closeUSD 0.082026-08-20
Fuss Brands stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-20.79%USD 0.102026-06-23
1 month-20.79%USD 0.102026-06-23
3 month-20.79%USD 0.102026-05-22
Year to date+42.86%USD 0.062025-12-31
1 year+60%USD 0.052025-08-18
3 year-34.69%USD 0.122023-08-14
5 year-98.19%USD 4.422021-08-20
Since inception-100%USD 23,349.011997-08-21

Fuss Brands Financials at a Glance

Market Cap

$1.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$149.44K

EPS (TTM)

-$0.01

P/E Ratio

-10.53

Dividend

$0.00

Beta (Volatility)

-16.92 (Low)

Price

$0.08

Volume

15,790

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.05 - $0.20

Estimated Earnings Date

Jun 9, 2025

FBDS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fuss Brands

China Botanic Pharmaceutical Inc. is a company focused on identifying and pursuing new commercial opportunities in the United States. The strategic aim includes exploring potential acquisitions of existing operating entities through various methods such as reverse mergers or asset purchases.

Products and Services
  • Exploration of acquisition opportunities in the pharmaceutical sector
  • Potential for reverse mergers with existing companies
  • Focus on expanding operations within the U.S. market
Growth Outlook
  • Company aims to leverage strategic acquisitions to enhance market presence
  • Exploration of diverse business opportunities in the pharmaceutical industry
  • Potential for significant growth through operational expansion
Financial Highlights
  • Recent quarterly net income of -$22,155 indicates ongoing operational challenges
  • Trailing twelve months (TTM) P/E ratio of -48.10 reflects current financial performance
  • Cash and cash equivalents stood at $633 as of July 31, 2025
China Botanic Pharmaceutical Inc. has a long history, having been founded in 1988 and previously known as Renhuang Pharmaceuticals, Inc. The company currently operates without substantial business activities but is actively seeking to reposition itself within the market. The focus on acquisitions and strategic partnerships may provide pathways for future growth, although recent financial data indicates challenges that need to be addressed. Investors may find the company's potential for expansion and strategic direction noteworthy as it navigates the complexities of the pharmaceutical landscape.
AI Generated • Aug 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

1

CEO

Cheskel Meisels

Website

www.anzacapital.com

Headquarters

New York, NY 10004, US

FBDS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

5.72%

Return on Capital

N/A

Return on Assets

-19.82%

Earnings Yield

-9.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

21.45M

Volume

15.79K

Avg. Volume

248.25

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$143.64K

EBITDA

-$42.32K

Operating Cash Flow

-$157.59K

Capital Expenditure

$0.00

Free Cash Flow

-$157.59K

Cash & ST Invst.

$633.00

Total Debt

$682.89K

Fuss Brands Performance Analysis

Fuss Brands annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-10-31USD 0N/A
20222022-10-31USD 0N/A
20232023-10-31USD 0N/A
20242024-10-31USD 0N/A
Fuss Brands sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-10-31N/A
Q12025-01-31N/A
Q22025-04-30N/A
Q32025-07-31N/A
Fuss Brands annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-10-31USD -0.23N/A
20222022-10-31USD -0.01-93.8%
20232023-10-31USD -0.03120.7%
20242024-10-31USD -0.14367.0%
Fuss Brands sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-10-3137.5%
Q12025-01-31-160.0%
Q22025-04-3071.8%
Q32025-07-319.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.72MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.72M

N/A

Employees

1

N/A

Net Income

-$22.16K

+52.2%

EBITDA

-$20.14K

N/A

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$633.00

-93.0%

Total Debt

$682.89K

+28.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$682.89K

+28.0%

Return on Assets

-19.82%

N/A

Return on Invested Capital

5.24%

N/A

Free Cash Flow

-$26.43K

+80.8%

Operating Cash Flow

-$26.43K

+80.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CCWFChurch & Crawford, Inc.
$0.00+0.00%
FCGDFirst Colombia Gold Corp.
$0.00+0.00%
PUGEPuget Technologies, Inc.
$0.00+0.00%
APSIAqua Power Systems Inc.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
DAICCid HoldCo
$5.31+0.37%
NVDANvidia
$212.44-0.00%
SNAPSnap
$5.57-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.03-0.01%

Questions About FBDS

What is the current price of Fuss Brands?

Fuss Brands is trading at $0.08 per share.

What is the 52-week range for Fuss Brands?

Over the past 52 weeks, Fuss Brands has traded between $0.05 and $0.20.

How much debt does Fuss Brands have?

As of the most recent reporting period, Fuss Brands reported total debt of $682.89K.

How much cash does Fuss Brands have on hand?

Fuss Brands reported $633.00 in cash and cash equivalents in its most recent financial results.

What is Fuss Brands’s dividend yield?

Fuss Brands does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services